Cargando…
Neratinib-Induced Duodenal Ulcer: A Case Report
We report a case of a 37-year-old woman who developed a duodenal ulcer while receiving adjuvant neratinib for HER2 positive breast cancer. The clinical course of abdominal pain was strongly correlated with the use of neratinib. An esophagogastroduodenoscopy (EGD) was performed and confirmed the diag...
Autores principales: | Moftakhar, Bahar, Kharel, Prakash, Niraula, Sujan, Gandhi, Shipra, Falkson, Carla, Dhakal, Ajay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315670/ https://www.ncbi.nlm.nih.gov/pubmed/32636634 http://dx.doi.org/10.1177/1178223420935871 |
Ejemplares similares
-
PI3Kinase Inhibition in Hormone Receptor-Positive Breast Cancer
por: Dhakal, Ajay, et al.
Publicado: (2021) -
Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature
por: Kharel, Prakash, et al.
Publicado: (2018) -
A Case of Duodenal Anisakiasis with Duodenal Ulcer
por: Hwang, David, et al.
Publicado: (2012) -
Sarilumab: Perforated duodenal ulcer: case report
Publicado: (2021) -
Neratinib for breast cancer
Publicado: (2019)